About 300 reports

  • Acute lymphocytic leukemia market in EMEA
  • Acute lymphocytic leukemia market in Americas
  • Leukemia
  • Alcon, Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Novartis AG

Key Features of the Report: - Chronic Myeloid Leukemia Patient Flow - Chronic Myeloid Leukemia Prevalence - Chronic Myeloid Leukemia Diagnosed Patients - Chronic Myeloid Leukemia Treated Patients

  • Leukemia
  • Europe
  • France
  • World
  • Forecast

Key Features of the Report: - Acute Myeloid Leukemia Patient Flow - Acute Myeloid Leukemia Prevalence - Acute Myeloid Leukemia Diagnosed Patients - Acute Myeloid Leukemia Treated Patients

  • Leukemia
  • Europe
  • France
  • World
  • Forecast
  • Leukemia Treatment Drugs Supply and Demand
  • Leukemia Treatment Drugs Imports and Exports
  • Leukemia
  • China
  • Market Size
  • Supply
  • Trade
  • 2.2.1 LEUKEMIA
  • 2.3.1 LEUKEMIA
  • Leukemia
  • World
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • Leukemia Treatment Drugs Supply and Demand
  • Leukemia Treatment Drugs Capacity in China
  • Leukemia
  • China
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • 6.7 ACUTE PROMYELOCYTIC LEUKEMIA
  • TREATMENT GUIDELINES FOR ACUTE MYELOID LEUKEMIA
  • Leukemia
  • Astellas Pharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Celgene Corporation
  • Novartis AG
  • Leukemia Treatment Drugs Import
  • Leukemia Treatment Drugs
  • Leukemia
  • China
  • Trade
  • Lijun Pharmaceutical Co., Ltd.
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd
  • Leukemia Treatment Drugs Import
  • Leukemia Treatment Drugs
  • Leukemia
  • China
  • Demand
  • Market Size
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd
  • FORECAST: CHRONIC MYELOID LEUKEMIA
  • Forecast: Chronic Myeloid Leukemia
  • Leukemia
  • Europe
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.
  • EPIDEMIOLOGY: ACUTE LYMPHOBLASTIC LEUKEMIA
  • FORECAST: ACUTE LYMPHOBLASTIC LEUKEMIA
  • Leukemia
  • Amgen Inc.
  • ARIAD Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Hairy Cell Leukemia Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Hairy Cell Leukemia Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hairy Cell Leukemia pipeline products, Hairy Cell

  • Leukemia
  • France
  • Germany
  • Italy
  • Market Size

Chronic Lymphocytic Leukemia Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Chronic Lymphocytic Leukemia Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Chronic Lymphocytic Leukemia pipeline pro

  • Leukemia
  • France
  • Germany
  • Italy
  • Market Size

Chronic Myeloid Leukemia Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Chronic Myeloid Leukemia Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Chronic Myeloid Leukemia pipeline products, Chron

  • Leukemia
  • France
  • Germany
  • Italy
  • Market Size

Acute lymphocytic Leukemia Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Acute lymphocytic Leukemia Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acute lymphocytic Leukemia pipeline products,

  • Leukemia
  • France
  • Germany
  • Italy
  • Market Size

Acute Myeloid Leukemia Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Acute Myeloid Leukemia Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Acute Myeloid Leukemia pipeline products, Acute Myelo

  • Leukemia
  • France
  • Germany
  • Italy
  • Market Size
  • 5.2.2 MELANOMA
  • Date
  • Leukemia
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • Hematological Cancers Therapeutics Market, Global, Leukemia Pipeline First-in-Class and Established Molecular
  • Hematological Cancers Therapeutics Market,
  • Leukemia
  • World
  • Market Size
  • Celgene Corporation
  • Novartis AG

Leukemia can be chronic or acute depending on the maturity of the cells.

  • Cancer
  • Leukemia
  • World
  • Market Size
  • Middle East & Africa Leukemia Inhibitory Factor Market by Geography
  • South America Leukemia Inhibitory Factor Market by Geography
  • Leukemia
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited

Based on leukemia type the market is categorized into chronic leukemia, acute leukemia, chronic myeloid leukemia, acute myeloid leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, chronic lymphatic leukemia, and

  • Leukemia
  • United States
  • World
  • Forecast
  • Market Size
  • EUROPEAN COMMISSION APPROVES AMGEN'S BLINCYTO (BLINATUMOMAB) FOR THE TREATMENT OF ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE RELAPSED OR REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
  • FDA APPROVES BLINCYTO (BLINATUMOMAB) FOR USE IN PEDIATRIC PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
  • Leukemia
  • Therapy
  • United States
  • Demand
  • Amgen Inc.

Key Features of the Report: - Acute Myeloid Leukemia Patient Flow - Acute Myeloid Leukemia Prevalence - Acute Myeloid Leukemia Diagnosed Patients - Acute Myeloid Leukemia Treated Patients

  • Leukemia
  • Europe
  • France
  • Germany
  • Forecast

Key Features of the Report: - Chronic Myeloid Leukemia Patient Flow - Chronic Myeloid Leukemia Prevalence - Chronic Myeloid Leukemia Diagnosed Patients - Chronic Myeloid Leukemia Treated Patients

  • Leukemia
  • Europe
  • France
  • Germany
  • Forecast
  • Leukemia Treatment Drugs Supply and Demand
  • Leukemia Treatment Drugs Industry Capacity
  • Leukemia
  • China
  • Nanjing Aosaikang Medicinal Group
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

leukemia, 2014 - 2025 (USD Billion) TABLE ## North America hematologic malignancies market estimates and forecasts, by Therapy, 2014 - 2025 (USD Billion) TABLE ## U. S. hematologic malignancies market estimates and forecasts, by type, 2014 - 2025 (USD Billion) TABLE ## U. S. hematologic malignan

  • Cancer
  • Leukemia
  • Pathology
  • World
  • Forecast

Global Acute Lymphocytic Leukemia Market, by Region, (USD Million) 2014 – 2022 ##. ## Introduction ##. ## North America ##. ##. ## North America Acute Lymphocytic Leukemia Market, by Therapeutics Type (USD Million) ##. ##. ## North America Acute Lymphocytic Leukemia Market, by Route of Ad

  • Leukemia
  • Europe
  • World
  • Forecast
  • Market Size
  • LEUKEMIA
  • LEUKEMIA: CLASSIFICATION
  • Leukemia
  • Demand
  • Market Size
  • AbbVie Inc.
  • Seattle Genetics, Inc.
  • EFFICACY RESULTS OF GLEEVEC IN PH+ ALL (ACUTE LYMPHOID LEUKAEMIA)
  • NEWS AROUND ICLUSIG
  • Leukemia
  • Europe
  • ARIAD Pharmaceuticals, Inc.
  • Incyte Corporation
  • Otsuka Pharmaceutical Co., Ltd.

LEUKEMIA MARKET OPPORTUNITY Table ##-##: Leukemia Overview by Type Figure ##-##: Distribution of Leukemia Cases by Type Figure ##-##: Global Incidence and Mortality of Leukemia by Country, 2012* THE HEAVY HITTERS IN LEUKEMIA TREATMENT: CURRENT MARKET LANDS

  • Leukemia
  • Oncology
  • Pathology
  • World
  • Market Size